First Page | Document Content | |
---|---|---|
Medicine Antiretroviral drug Protease inhibitor Food and Drug Administration HIV Polypharmacy Norfloxacin Clinical trial Pharmaceutical sciences Pharmacology Health | 21-548S028 Fosamprenavir Clinical BPCA & PREAAdd to Reading ListSource URL: www.fda.govDownload Document from Source WebsiteFile Size: 1,93 MBShare Document on Facebook |